Heart Failure After PCI: The Risk That Outlasts the Procedure

Clinical trials have historically grouped post-PCI adverse events — bleeding, recurrent ACS, heart failure — into a single composite endpoint. A 2026 study in JACC: Cardiovascular Interventions, led by Takahiro Suzuki and colleagues at Keio University School of Medicine, broke them apart. The hierarchy it revealed changes how physicians should think about post-PCI survival.

Not all complications are equal

The study tracked more than 10,000 patients across 15 facilities. Heart failure hospitalizations occurred in 4.7% of patients — less common than ACS or major bleeding. But the two-year mortality rate for those patients was 25.4%, nearly three times the rate for ACS and almost three times the rate for major bleeding. In a fully adjusted model, heart failure accounted for 20.1% of total post-PCI mortality — roughly five times the contribution of recurrent heart attacks.

“Post-PCI patients who experience heart failure hospitalizations should be considered at exceptionally high risk and may benefit from enhanced follow-up and intervention strategies.”

Takahiro Suzuki, MD, Keio University School of Medicine

The median time to death was 306 days. That's a full year of potential intervention — if the monitoring infrastructure exists to bring forward the subclinical signals that precede a heart failure hospitalization in this population.

Continuous oversight for the highest-risk window

Standard post-PCI follow-up relies on office visits spaced weeks to months apart. For a population where heart failure drives one-fifth of total mortality, episodic check-ins leave too much unobserved. Our care team reviews daily blood pressure, heart rate, and weight data transmitted by the SYNC-PREVENT™ platform 365 days a year, against physician-established parameters — so the edema and congestion patterns the Suzuki study identified as primary symptoms reach the physician weeks before they would otherwise surface in an office visit. Consistent tracking of these biomarkers provides the treating physician with longitudinal data to support timely clinical decision-making as part of an overall care plan.

The care coordination layer ensures the interventional cardiologist, heart failure specialist, and primary care physician share a single monitoring record. Post-PCI survival becomes a unified clinical priority rather than a series of disconnected follow-ups across separate offices — each assuming someone else is watching for the signal that matters most.